🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single arm, open label, single center, prospective study was designed ...
Status
Unknown
Location
Beijing Union Medical College Hospital
Start Date
2020-06-08
Trial ID
NCT04453930
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of SHR-1210...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2019-01-19
Trial ID
NCT03816553
This is a randomized, open-label, international, multi-center, phase III tr...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-10
Trial ID
NCT03764293
This is a Phase II , Open-label , Investigator-initiated Trail of SHR-1210 ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-01-30
Trial ID
NCT03793725
This is a randomized, open-label, multi-center, phase III trial to evaluate...
Status
Completed
Location
Beijing Cancer Hospital, Peking University
Start Date
2019-03-07
Trial ID
NCT03813784
Treatments Being Tested
This is an open-label，single-arm, phase II exploratory study that evaluates...
Status
Unknown
Location
Tongji Hospital，Tongji Medical College Affiliated，Huazhong University of Science ＆ Technology
Start Date
2022-01-14
Trial ID
NCT05142865
Treatments Being Tested
This is a study of Camrelizumab (SHR-1210) and Apatinb for unresectable Rec...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2020-11-18
Trial ID
NCT04609176
Treatments Being Tested
In this one-arm study, histologically or cytologically confirmed advanced N...
Status
Unknown
Location
Hunan cancer Hospital
Start Date
2019-01-30
Trial ID
NCT04239443
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of simple...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2019-11-01
Trial ID
NCT04204577
Treatments Being Tested
This an open-label，Non-Randominzed Phase 2 study to evaluate the Safety and...
Status
Completed
Location
The Second Affiliated Hospital Of Anhui Medical University
Start Date
2017-04-24
Trial ID
NCT03092895